Filing Details

Accession Number:
0001209191-22-027651
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-06 17:09:58
Reporting Period:
2022-04-14
Accepted Time:
2022-05-06 17:09:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-14 19 $2.71 15,796 No 4 P Direct
Common Stock Acquisiton 2022-04-18 19 $2.63 15,815 No 4 P Direct
Common Stock Acquisiton 2022-04-19 19 $2.69 15,834 No 4 P Direct
Common Stock Acquisiton 2022-04-20 19 $2.74 15,853 No 4 P Direct
Common Stock Acquisiton 2022-04-21 19 $2.75 15,872 No 4 P Direct
Common Stock Acquisiton 2022-04-22 19 $2.73 15,891 No 4 P Direct
Common Stock Acquisiton 2022-04-25 20 $2.62 15,911 No 4 P Direct
Common Stock Acquisiton 2022-04-26 20 $2.53 15,931 No 4 P Direct
Common Stock Acquisiton 2022-04-27 20 $2.41 15,951 No 4 P Direct
Common Stock Acquisiton 2022-04-28 20 $2.51 15,971 No 4 P Direct
Common Stock Acquisiton 2022-04-29 20 $2.44 15,991 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.